our first product is brainSee:
fDA-breakthrough, pending Marketing approval

BrainSee Is A Medical Device

BrainSee is a clinical software designed to help physicians evaluate the prognosis of patients diagnosed with amnestic mild cognitive impairment (aMCI).

BrainSee’s algorithm combines a patient’s brain MRI with cognitive test scores and generates a score between 0 and 100 that helps the doctor determine the likelihood of progression from mild cognitive impairment to Alzheimer’s dementia.